Xilio Therapeutics Funding: $95M Raised, Series C (2021)
Xilio Therapeutics is a Biotech company based in Waltham. It has raised $95M in total funding. Latest round: Series C.
Xilio Therapeutics funding overview
Xilio Therapeutics is a Biotech company based in Waltham. Xilio Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2021. The round record for Xilio Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors and 3 others. 9 distinct backers are named across the disclosed rounds.
Xilio Therapeutics at a glance
Total raised
$95M
Latest round
Series C
Latest round date
February 2021
Industry
Biotech
Headquarters
Waltham
Notable investors
Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors, Takeda Ventures, RiverVest Venture Partners
Frequently asked about Xilio Therapeutics funding
How much has Xilio Therapeutics raised?
Xilio Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Xilio Therapeutics?
Rock Springs Capital, Bain Capital Life Sciences, Deerfield Management Company, RA Capital Management, Atlas Venture, SV Health Investors are named among the investors backing Xilio Therapeutics.
What was the latest Xilio Therapeutics funding round?
The most recent disclosed round is a Series C, announced in February 2021.
Where is Xilio Therapeutics based?
Xilio Therapeutics is based in Waltham.
What sector does Xilio Therapeutics operate in?
Xilio Therapeutics is tracked under Biotech from Waltham, with $95M in disclosed funding.
When did Xilio Therapeutics last raise?
The last disclosed Xilio Therapeutics round closed in February 2021 at Series C.
Xilio Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Waltham below to benchmark round size and investor mix.
